89 related articles for article (PubMed ID: 23436911)
1. Regarding the letter to the editor 'AIB1 and its significant role in tumor pathogenesis in systemic malignancies: beyond breast carcinomas' by Kapoor and Shailendra in Annals of Oncology.
Alkner S
Ann Oncol; 2013 May; 24(5):1414-5. PubMed ID: 23436911
[No Abstract] [Full Text] [Related]
2. AIB1 and its significant role in tumor pathogenesis in systemic malignancies: beyond breast carcinomas.
Kapoor S
Ann Oncol; 2013 May; 24(5):1414. PubMed ID: 23446091
[No Abstract] [Full Text] [Related]
3. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.
Alkner S; Bendahl P; Grabau D; Malmström P; Fernö M; Rydén L;
Ann Oncol; 2013 May; 24(5):1244-52. PubMed ID: 23230135
[TBL] [Abstract][Full Text] [Related]
4.
Jahangiri R; Mosaffa F; Emami Razavi A; Teimoori-Toolabi L; Jamialahmadi K
J Oncol Pharm Pract; 2022 Mar; 28(2):310-325. PubMed ID: 33509057
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.
Alkner S; Jensen MB; Rasmussen BB; Bendahl PO; Fernö M; Rydén L; Mouridsen H;
Breast Cancer Res Treat; 2017 Nov; 166(2):481-490. PubMed ID: 28766132
[TBL] [Abstract][Full Text] [Related]
6. Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
Alkner S; Bendahl PO; Ehinger A; Lövgren K; Rydén L; Fernö M
PLoS One; 2016; 11(3):e0150977. PubMed ID: 26959415
[TBL] [Abstract][Full Text] [Related]
7. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
Burandt E; Jens G; Holst F; Jänicke F; Müller V; Quaas A; Choschzick M; Wilczak W; Terracciano L; Simon R; Sauter G; Lebeau A
Breast Cancer Res Treat; 2013 Feb; 137(3):745-53. PubMed ID: 23322234
[TBL] [Abstract][Full Text] [Related]
9. Expression of selected proteins in breast cancer brain metastases.
Gojis O; Kubecova M; Rosina J; Vranova J; Celko M; Frajerova D; Zmrhal J; Zahumensky J; Bacova T; Baca V; Mandys V; Kucera E
Folia Histochem Cytobiol; 2013; 51(3):213-8. PubMed ID: 24203627
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of the tumor suppressor DRO1 by AIB1.
Ferragud J; Avivar-Valderas A; Pla A; De Las Rivas J; Font de Mora J
FEBS Lett; 2011 Oct; 585(19):3041-6. PubMed ID: 21871888
[TBL] [Abstract][Full Text] [Related]
12. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
13. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.
List HJ; Reiter R; Singh B; Wellstein A; Riegel AT
Breast Cancer Res Treat; 2001 Jul; 68(1):21-8. PubMed ID: 11678305
[TBL] [Abstract][Full Text] [Related]
14. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.
Oh A; List HJ; Reiter R; Mani A; Zhang Y; Gehan E; Wellstein A; Riegel AT
Cancer Res; 2004 Nov; 64(22):8299-308. PubMed ID: 15548698
[TBL] [Abstract][Full Text] [Related]
15. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
[TBL] [Abstract][Full Text] [Related]
16. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
[TBL] [Abstract][Full Text] [Related]
17. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
Azorsa DO; Cunliffe HE; Meltzer PS
Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
[TBL] [Abstract][Full Text] [Related]
18. Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1.
An Y; Wu J; Yang B; Zhu Z; Gao M; Yu C; Yang CJ
J Mol Evol; 2015 Dec; 81(5-6):179-85. PubMed ID: 26458993
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
